# Chest pain

<table><colgroup><col> <col></colgroup><tbody><tr><td><p><b>Disorder</b></p></td><td><p><b>Typical Characteristics &amp; Diagnostic Studies</b></p></td></tr><tr><td colspan="2"><p><b><i>Cardiac Causes</i></b></p></td></tr><tr><td><p><b>ACS</b></p><p>(15–25% of chest pain in ED)</p></td><td><p>Substernal “pressure” (! LR 1.3) → neck, jaw, arm (! LR 1.3–1.5)</p><p>Sharp, pleuritic, positional, or reprod. with palp all with ⊕ LR ≤0.35</p><p>Diaphoresis (⊕ LR 1.4), dyspnea (⊕ LR 1.2), a/w exertion (⊕ LR 1.5–1.8)</p><p>≈ prior MI (⊕ LR 2.2); ↓ with NTG/rest (but not reliable; <i>Annals EM</i> 2005;45:581)</p><p>± ECG ∆s: STE, STD, TWI, Qw. ± ↑ Troponin.</p></td></tr><tr><td><p><b>Pericarditis &amp; myo- pericarditis</b></p></td><td><p>Sharp pain → trapezius, ↑ with respiration, ↓ with sitting forward. ± Pericardial friction rub. ECG ∆s (diffuse STE &amp; PR ↓, opposite in aVR) ± pericardial effusion. If myocarditis, same as above + ↑ Tn and ± signs and symptoms HF and ↓ EF.</p></td></tr><tr><td><p><b>Aortic dissection</b></p></td><td><p>Sudden severe tearing pain (absence ⊖ LR 0.3). ± Asymm (&gt;20 mmHg) BP or pulse (⊕ LR 5.7), focal neuro deficit (⊕ LR &gt;6), AI, widened mediast. on CXR (absence ⊖ LR 0.3); false lumen on imaging. (<i>JAMA</i> 2002;287:2262)</p></td></tr><tr><td colspan="2"><p><b><i>Pulmonary Causes</i></b></p></td></tr><tr><td><p><b>Pneumonia</b></p></td><td><p>Pleuritic; dyspnea, fever, cough, sputum. ↑ RR, crackles. CXR infiltrate.</p></td></tr><tr><td><p><b>Pleuritis</b></p></td><td><p>Sharp, pleuritic pain. ± Pleuritic friction rub.</p></td></tr><tr><td><p><b>PTX</b></p></td><td><p>Sudden onset, sharp pleuritic pain. Hyperresonance, ↓ BS. PTX on CXR.</p></td></tr><tr><td><p><b>PE</b></p></td><td><p>Sudden onset pleuritic pain. ↑ RR &amp; HR, ↓ S<sub>a</sub>O<sub>2</sub>, ECG ∆s (sinus tach, RAD, RBBB, S<sub>I</sub>Q<sub>III</sub>T<sub>III</sub>, TWI V<sub>1</sub>–V<sub>4</sub>, occ STE V<sub>1</sub>–V<sub>3</sub>), + CTA or V/Q, ± ↑ Tn.</p></td></tr><tr><td><p><b>Pulm HTN</b></p></td><td><p>Exertional pressure, DOE. ↓ S<sub>a</sub>O<sub>2</sub>, loud P<sub>2</sub>, RV heave, right S<sub>3</sub> and/or S<sub>4</sub>.</p></td></tr><tr><td colspan="2"><p><b><i>GI Causes</i></b></p></td></tr><tr><td><p><b>Esophageal reflux</b></p></td><td><p>Substernal burning, acid taste in mouth, water brash. ↑ by meals, recumbency; ↓ by antacids. EGD, manometry, pH monitoring.</p></td></tr><tr><td><p><b>Esoph spasm</b></p></td><td><p>Intense substernal pain. ↑ by swallowing, ↓ by NTG/CCB. Manometry.</p></td></tr><tr><td><p><b>Mallory-Weiss</b></p></td><td><p>Esoph tear precipitated by vomiting. ± Hematemesis. Dx with EGD.</p></td></tr><tr><td><p><b>Boerhaave</b></p></td><td><p>Esoph rupture. Severe pain, ↑ with swallow. Mediastinal air palpable &amp; on CT.</p></td></tr><tr><td><p><b>PUD</b></p></td><td><p>Epigastric pain, relieved by antacids. ± GIB. EGD, ± <i>H. pylori</i> test.</p></td></tr><tr><td><p><b>Biliary dis.</b></p></td><td><p>RUQ pain, N/V. ↑ by fatty foods. RUQ U/S; ↑ LFTs.</p></td></tr><tr><td><p><b>Pancreatitis</b></p></td><td><p>Epigastric/back discomfort. ↑ amylase &amp; lipase; abd CT.</p></td></tr><tr><td colspan="2"><p><b><i>Musculoskeletal and Miscellaneous Causes</i></b></p></td></tr><tr><td><p><b>Costochond</b></p></td><td><p>Localized sharp pain. ↑ with movement. Reproduced by palpation.</p></td></tr><tr><td><p><b>Zoster</b></p></td><td><p>Intense unilateral pain. Pain may precede dermatomal rash.</p></td></tr><tr><td><p><b>Anxiety</b></p></td><td><p>“Tightness,” dyspnea, palpitations, other somatic symptoms</p></td></tr></tbody></table>

(_Braunwald’s Heart Disease_, 11th ed, 2018; _JAMA_ 2015;314:1955)

### Initial approach

• **Focused history:** quality, severity, location, radiation; provoking/palliating factors; intensity at onset; duration, freq, & pattern; setting; assoc 症狀; cardiac hx & risk factors

• **Targeted exam:** VS (incl. BP in both arms); gallops, murmurs, rubs; signs of vascular dis. (carotid/femoral bruits, ↓ pulses) or CHF; lung & abd. exam; chest wall for reproducibility

• **12-lead ECG:** obtain within 10 min; comp to priors & obtain serial ECGs; consider _posterior leads_ (V7–V9) to ✔ for posterior STEMI if: hx c/w ACS but stnd ECG unrevealing; ST ↓ V1–V3 (ant ischemia vs. post STEMI) with refractory angina; or R/S >1 in V1–V2

• **CXR;** other imaging (echo, PE CTA, etc.) as indicated based on H&P and initial testing

• **Troponin:** >_99th %ile with rise and/or fall in approp. setting is dx of AMI_ (_Circ_ 2018;138:e618)

Detectable 1–6 h after injury, peaks 24 h, may be elevated for 7–14 d in STEMI ✔ at presentation & 3–6 h later; repeat if 臨床or ECG ∆s; ? sex-specific cutpoints If high-sens Tn (hsTn) assay, can ✔ at presentation & 1 h later; assess level & Δ

• Causes for ↑ Tn other than plaque rupture (= “type 1 MI”): (1) Supply-demand mismatch not due to ∆ in CAD (= “type 2 MI”; eg, ↑↑ HR, shock, HTN crisis, spasm, severe AS), (2) non-ischemic injury (myocarditis/toxic CMP, cardioversion, cardiac contusion) or (3) multifactorial (PE, sepsis, severe HF, renal failure, Takotsubo, infilt dis.)

• CK-MB: less Se & Sp than Tn (other sources: skel. muscle, intestine, etc.); CK-MB/CK ratio >2.5 → cardiac source. Limited utility: ? higher bar for post-revasc MI; early reMI.

### Early noninvasive imaging

• Low prob of ACS (eg, ⊖ ECG & Tn) & stable → outPt or inPt noninv. fxnal or imaging test (qv)

• CCTA with high NPV, low PPV. ↓ LOS c/w fxnal testing (_NEJM_ 2012;366:1393). In stable outPt with CP, CCTA added to standard of care ↑ early but not overall angiography/revasc; ↑ use of preventive med Rx, and ↓ coronary death/MI at 5 y (_NEJM_ 2018;379:924).

• “Triple 排除” CT angiogram sometimes performed to 排除 CAD, PE, AoD if dx unclear
